Table 6 Comparison of microarray analysis between two studies
Gene | Fold change in John-Aryankalayil et al | Fold change in our study |
|---|---|---|
Significantly regulated in current study (p < 0.05) | Â | Â |
SILV (silver homolog) | 2.2 | 2.3 |
CD31 (PECAM1) | 2.1 | 2.2 |
C5orf13 | 2.5 | 2.2 |
RBP1 | 3.6 | 2.0 |
Von Willebrand factor | 2.5 | 2.0 |
RAB31 | 2.0 | 1.7 |
Clathrin (CLTB) | 2.4 | 1.7 |
DAB2 | 2.1 | 1.5 |
S100 A9 (calgranulin B) | 2.2 | 1.4 |
MAP 17 | 2.4 | 1.4 |
MIP-4 | 4.9 | 1.4 |
ECM1 | 3.2 | 1.3 |
COMP | 2.0 | 1.3 |
versican | 3.3 | 1.2 |
TRAP100 | 5.0 | 1.2 |
CD32 receptor | 2.9 | 1.2 |
mRNA, clone AL050154 | 2.8 | 1.1 |
CLIC2 | 0.5 | 1.1 |
Prostaglandin F2alpha receptor | 3.2 | 1.1 |
Not significantly regulated in current study (p > 0.05) | Â | Â |
NDRG4 | 3.1 | 1.1 |
Carbonic anhydrase CA1 | 0.5 | 1.1 |
ABCG1 | 2.3 | 1.1 |
ADPRTL2 | 2.3 | 1.1 |
Casein kinase II | 2.5 | 1.0 |
Collagen III | 4.1 | 1.0 |
Fibronectin | 8.5 | 1.0 |
LZTR1 | 2.2 | 1.0 |
Collagen VI | 2.1 | 1.0 |
Myosin heavy chain II | 3.1 | 0.9 |
FUBP | 0.5 | 0.9 |
Ephrin-A1 | 0.5 | 0.9 |
Per1 | 0.5 | 0.9 |
Lipocalin 2 | 2.4 | 0.9 |